Corbus Pharmaceuticals Holdings, Inc. 4
4 · Corbus Pharmaceuticals Holdings, Inc. · Filed Oct 7, 2016
Insider Transaction Report
Form 4
Tepper Mark
President and CSO
Transactions
- Award
Stock Option(right to buy)
2016-10-06+150,000→ 150,000 totalExercise: $8.71Exp: 2026-10-06→ Common Stock (150,000 underlying)
Footnotes (1)
- [F1]The option award was made in accordance with the terms of the issuer's 2014 Equity Compensation Plan. 25% of the option vests on October 6, 2017, with the remaining 75% of the option vesting in equal monthly installments over a period of 36 months commencing on November 6, 2017.